(1 - 9 von 14
)
Evotec and Apeiron Biologics build Pain Alliance -
www.bionity.com
Dr Hans Loibner, Chief Executive Officer at Apeiron Biologics, commented: "Combining our two companies' skills is an excellent way to move forward with this innovative and promising project. We have worked with Evotec in ...
APEIRON: Cancer Immunotherapy Wins Pharma Deal
www.lisavienna.at
Oct 4, — Dr. Hans Loibner, APEIRON Biologics' Chief Executive Officer comments: "The global license for commercialization of our most advanced ... › news › apeiron-cancer-immun...
apnews.com › ...APEIRON and Evotec Achieve First Milestone in AP News
apnews.com
Dr Hans Loibner, Chief Executive Officer of APEIRON Biologics, said: “We are delighted by the progress made in our collaboration with Evotec ...
DGAP-News: Evotec and Apeiron Biologics announce collaboration on...
www.wallstreet-online.de
Dr Hans Loibner, Chief Executive Officer of Apeiron Biologics, added: ´We were excited about the outcome of the primary screen and look forward to refining the hit
sortiert nach Relevanz / Datum